Case Report
Published on 24 Jun 2024
Case report: Precise NGS and combined bevacizumab promote durable response in ALK-positive lung adenocarcinoma with multiple-line ALK-TKI resistance
in Thoracic Oncology
![Case report: Precise NGS and combined bevacizumab promote durable response in ALK-positive lung adenocarcinoma with multiple-line ALK-TKI resistance](https://www.frontiersin.org/files/myhome article library/1419306/1419306_Thumb_400.jpg)
- 451 views
Case Report
Published on 24 Jun 2024
in Thoracic Oncology
Original Research
Published on 24 Jun 2024
in Thoracic Oncology
Original Research
Published on 21 Jun 2024
in Thoracic Oncology
Review
Published on 21 Jun 2024
in Thoracic Oncology
Case Report
Published on 21 Jun 2024
in Thoracic Oncology
Original Research
Published on 20 Jun 2024
in Thoracic Oncology
Mini Review
Published on 18 Jun 2024
in Thoracic Oncology
Original Research
Published on 18 Jun 2024
in Thoracic Oncology
Case Report
Published on 18 Jun 2024
in Thoracic Oncology
Original Research
Published on 17 Jun 2024
in Thoracic Oncology
Case Report
Published on 17 Jun 2024
in Thoracic Oncology
Systematic Review
Published on 11 Jun 2024
in Thoracic Oncology
Review
Published on 11 Jun 2024
in Thoracic Oncology
Case Report
Accepted on 10 Jun 2024
in Thoracic Oncology
Editorial
Published on 07 Jun 2024
in Thoracic Oncology
Review
Published on 06 Jun 2024
in Thoracic Oncology